Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre
- PMID: 29422448
- DOI: 10.1016/j.ttbdis.2017.12.014
Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre
Abstract
A two-step testing strategy is recommended in serological testing for Lyme borreliosis; positive and indeterminate enzyme-linked immunosorbent assay (ELISA) results are confirmed with immunoblots. Several ELISAs quantify the concentration of antibodies tested, however, no recommendation exists for an upper cut-off value at which an IgG ELISA is sufficient and the immunoblot can be omitted. The study objective was to determine at which IgG antibody level an immunoblot does not have any additional predictive value compared to ELISA results. Data of adult patients who visited a tertiary Lyme centre between 2008 and 2014 were analysed. Both an ELISA (Enzygnost Lyme link VlsE IgG) and immunoblot (recomLine blot Borrelia) were performed. Clinical data were extracted from the patient's digital medical record. Positive predictive values (PPVs) for either previous or active infection with Borrelia burgdorferi s.l. were calculated for different cut-off ELISA IgG antibody levels where the immunoblot was regarded as reference test. In total, 1454 patients were included. According to the two-step test strategy, 486 (33%), 69 (5%) and 899 (62%) patients had positive, indeterminate and negative Borrelia IgG serology, respectively. At IgG levels of 500 IU/ml and higher, all immunoblots were positive, resulting in a 100% PPV (95% CI: 97.0-100). At IgG levels of 200 IU/ml and higher, the PPV was 99.3% (95% CI: 97.4-99.8). In conclusion, at IgG levels of 200 IU/ml and higher, an ELISA was sufficient to detect antibodies to Borrelia burgdorferi s.l. At those IgG levels, a confirmatory immunoblot may be omitted in patients referred to a tertiary Lyme centre. Before these results can be implemented in routine diagnosis of Lyme borreliosis, confirmation of the results is necessary in other patient populations and using other quantitative ELISAs and immunoblots.
Keywords: ELISA; Immunoblot; Lyme borreliosis; Positive predictive value; Serology.
Copyright © 2017 Elsevier GmbH. All rights reserved.
Similar articles
-
Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.Pathology. 2016 Apr;48(3):251-6. doi: 10.1016/j.pathol.2016.02.004. Epub 2016 Mar 5. Pathology. 2016. PMID: 27020501
-
Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.Eur J Clin Microbiol Infect Dis. 2008 May;27(5):349-54. doi: 10.1007/s10096-007-0445-7. Epub 2008 Jan 16. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18197445
-
Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.J Clin Microbiol. 2005 Aug;43(8):3602-9. doi: 10.1128/JCM.43.8.3602-3609.2005. J Clin Microbiol. 2005. PMID: 16081885 Free PMC article.
-
Diagnosis of lyme borreliosis in europe.Vector Borne Zoonotic Dis. 2003 Winter;3(4):215-27. doi: 10.1089/153036603322662200. Vector Borne Zoonotic Dis. 2003. PMID: 14733674 Review.
-
More specific bands in the IgG western blot in sera from Scottish patients with suspected Lyme borreliosis.J Clin Pathol. 2010 Aug;63(8):719-21. doi: 10.1136/jcp.2010.076307. Epub 2010 Jun 30. J Clin Pathol. 2010. PMID: 20595179 Review.
Cited by
-
Quantitative serological antibody testing for suspected neuroborreliosis.J Neurol. 2020 May;267(5):1476-1481. doi: 10.1007/s00415-020-09721-7. Epub 2020 Feb 1. J Neurol. 2020. PMID: 32008071 Free PMC article.
-
Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis.BMJ Glob Health. 2022 Jun;7(6):e007744. doi: 10.1136/bmjgh-2021-007744. BMJ Glob Health. 2022. PMID: 35697507 Free PMC article.
-
Quantitative multiplexed strategies for human Lyme disease serological testing.Exp Biol Med (Maywood). 2021 Jun;246(12):1388-1399. doi: 10.1177/15353702211003496. Epub 2021 Apr 1. Exp Biol Med (Maywood). 2021. PMID: 33794698 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical